Ryan J. Davey

10 Chittaway Road
Ourimbah, NSW 2258, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials.

Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials.

Journal: The Lancet. Oncology

Published: February 06, 2026

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

Journal: The Lancet. Oncology

Published: December 20, 2025

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.

Journal: International journal of radiation oncology, biology, physics

Published: December 10, 2024

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.

Journal: The Lancet. Oncology

Published: November 14, 2023

Efficacy of Normalisation of Advance Care Planning (NACP) for people with chronic diseases in hospital and community settings: a quasi-experimental study.

Efficacy of Normalisation of Advance Care Planning (NACP) for people with chronic diseases in hospital and community settings: a quasi-experimental study.

Journal: BMC health services research

Published: May 20, 2021

A cost-consequence analysis of normalised advance care planning practices among people with chronic diseases in hospital and community settings.

A cost-consequence analysis of normalised advance care planning practices among people with chronic diseases in hospital and community settings.

Journal: BMC health services research

Published: February 19, 2021

Prevalence of advance care planning practices among people with chronic diseases in hospital and community settings: a retrospective medical record audit.

Prevalence of advance care planning practices among people with chronic diseases in hospital and community settings: a retrospective medical record audit.

Journal: BMC health services research

Published: October 09, 2020

Study protocol to investigate the efficacy of normalisation of Advance Care Planning (ACP) for people with chronic diseases in acute and community settings: a quasi-experimental design.

Study protocol to investigate the efficacy of normalisation of Advance Care Planning (ACP) for people with chronic diseases in acute and community settings: a quasi-experimental design.

Journal: BMC health services research

Published: February 21, 2019

Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair.

Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair.

Journal: Oncotarget

Published: July 02, 2016

Metastatic melanoma treatment: Combining old and new therapies.

Metastatic melanoma treatment: Combining old and new therapies.

Journal: Critical reviews in oncology/hematology

Published: October 02, 2014

Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma.

Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma.

Journal: PloS one

Published: March 12, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026